121 related articles for article (PubMed ID: 7995048)
1. Application of the ATP-cell viability assay for assessment of biologic response modifiers in gynecologic cancer.
Angioli R; Sevin BU
Contrib Gynecol Obstet; 1994; 19():166-78. PubMed ID: 7995048
[No Abstract] [Full Text] [Related]
2. Application of the ATP-cell viability assay for assessment of in vitro radiation treatment response in gynecologic cancer cell lines.
Rodriguez M; Steren AJ
Contrib Gynecol Obstet; 1994; 19():156-65. PubMed ID: 7995047
[No Abstract] [Full Text] [Related]
3. Review of data on gynecologic cancer cell lines: potential applications of ATP-cell viability assays.
Nguyen HN; Sevin BU; Perras JP; Averette HE
Contrib Gynecol Obstet; 1994; 19():132-44. PubMed ID: 7995045
[No Abstract] [Full Text] [Related]
4. Evaluation of new drugs and combinations in gynecologic tumors and cancer cell lines with the ATP-cell viability assay.
Untch M; Sevin BU
Contrib Gynecol Obstet; 1994; 19():145-55. PubMed ID: 7995046
[No Abstract] [Full Text] [Related]
5. Potential use of the adenosine triphosphate cell viability assay in endometrial cancer.
Tam KF; Ng TY; Tsang PC; Li CF; Ngan HY
J Soc Gynecol Investig; 2006 Oct; 13(7):518-22. PubMed ID: 16979354
[TBL] [Abstract][Full Text] [Related]
6. ATP-cell viability assay methodology in both fresh gynecologic tumors and cell lines.
Köchli OR; Perras JP; Sevin BU
Contrib Gynecol Obstet; 1994; 19():108-21. PubMed ID: 7995042
[No Abstract] [Full Text] [Related]
7. In vivo/in vitro correlation of xenografts in nude mice and the ATP-cell viability assay.
Perras JP; Hurst J
Contrib Gynecol Obstet; 1994; 19():122-31. PubMed ID: 7995044
[No Abstract] [Full Text] [Related]
8. Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement.
Boente MP; Yordan EL; McIntosh DG; Grendys EC; Orandi YA; Davies S; Beck D; Graham JE; Miller A; Marshall R
Gynecol Oncol; 1993 Dec; 51(3):316-22. PubMed ID: 8112639
[TBL] [Abstract][Full Text] [Related]
9. Interferons as biomodulators of fluoropyrimidines in the treatment of colorectal cancer.
Makower D; Wadler S
Semin Oncol; 1999 Dec; 26(6):663-71. PubMed ID: 10606259
[TBL] [Abstract][Full Text] [Related]
10. Interferons in the treatment of malignancies.
Kardamakis D
In Vivo; 1991; 5(6):589-97. PubMed ID: 1810444
[TBL] [Abstract][Full Text] [Related]
11. Potential application of the ATP cell viability assay in the measurement of intrinsic radiosensitivity in cervical cancer.
Tam KF; Ng TY; Liu SS; Tsang PC; Kwong PW; Ngan HY
Gynecol Oncol; 2005 Mar; 96(3):765-70. PubMed ID: 15721424
[TBL] [Abstract][Full Text] [Related]
12. Focus on endometrial and cervical cancer.
Ellenson LH; Wu TC
Cancer Cell; 2004 Jun; 5(6):533-8. PubMed ID: 15193256
[No Abstract] [Full Text] [Related]
13. [Treatment outcomes in patients with unfavorable histologic type of endometrial carcinoma].
Litvinova TM; Kosenko IA
Vopr Onkol; 2006; 52(1):89-91. PubMed ID: 16715712
[TBL] [Abstract][Full Text] [Related]
14. Immunological monitoring and clinical trials of biological response modifiers.
Baseler MW; Urba WJ
Cancer Chemother Biol Response Modif; 1991; 12():231-50. PubMed ID: 1931445
[No Abstract] [Full Text] [Related]
15. [Adjuvant brachy- and percutaneous radiotherapy of endometrial carcinoma treated with primary surgery].
Willgeroth F
Gynakologe; 1994 Apr; 27(2):76-83. PubMed ID: 8039746
[No Abstract] [Full Text] [Related]
16. Early invasive disease: risk assessment and management.
Thomas GM; Stehman FB
Semin Oncol; 1994 Feb; 21(1):17-24. PubMed ID: 8310304
[No Abstract] [Full Text] [Related]
17. Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: a Gynecologic Oncology Group study.
Waggoner SE; Darcy KM; Fuhrman B; Parham G; Lucci J; Monk BJ; Moore DH;
Gynecol Oncol; 2006 Dec; 103(3):853-8. PubMed ID: 16815535
[TBL] [Abstract][Full Text] [Related]
18. Gynecologic cancer in the elderly.
Termrungruanglert W; Kudelka AP; Edwards CL; Delclos L; Verschraegen CF; Kavanagh JJ
Clin Geriatr Med; 1997 May; 13(2):363-79. PubMed ID: 9115456
[TBL] [Abstract][Full Text] [Related]
19. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
20. [Two cases of breast cancer, simultaneously associated with uterine cancer].
Saito C; Sagawa T; Negishi H; Begum S; Yamada H; Fujimoto S
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jul; 48(7):544-7. PubMed ID: 8754399
[No Abstract] [Full Text] [Related]
[Next] [New Search]
